MENU
+Compare
GILD
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$108.22
Change
-$0.58 (-0.53%)
Capitalization
90.79B

GILD Gilead Sciences Forecast, Technical & Fundamental Analysis

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GILD with price predictions
Jul 18, 2025

GILD in -1.48% downward trend, sliding for three consecutive days on July 18, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GILD declined for three days, in of 298 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GILD as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GILD turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 270 cases where GILD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.976) is normal, around the industry mean (5.632). P/E Ratio (16.196) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.451) is also within normal values, averaging (3.004). Dividend Yield (0.041) settles around the average of (0.161) among similar stocks. P/S Ratio (3.381) is also within normal values, averaging (3.643).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. GILD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GILD is expected to report earnings to rise 8.29% to $1.96 per share on August 05

Gilead Sciences GILD Stock Earnings Reports
Q2'25
Est.
$1.96
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.51
Q2'24
Beat
by $0.41
The last earnings report on April 24 showed earnings per share of $1.81, beating the estimate of $1.77. With 6.63M shares outstanding, the current market capitalization sits at 90.79B.
A.I.Advisor
published Dividends

GILD paid dividends on June 27, 2025

Gilead Sciences GILD Stock Dividends
А dividend of $0.79 per share was paid with a record date of June 27, 2025, and an ex-dividend date of June 13, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDVG42.46N/A
N/A
T. Rowe Price Dividend Growth ETF
AGIH24.62N/A
N/A
iShares Inflation Hdg U.S. Aggt Bd ETF
NANC42.12-0.04
-0.10%
Unusual Whales Subversive Dem Trd ETF
QQQ561.26-0.54
-0.10%
Invesco QQQ Trust
MAXI33.61-1.26
-3.61%
Simplify Bitcoin Strategy PLUS Inc ETF

GILD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-0.53%
AMGN - GILD
49%
Loosely correlated
-1.17%
BMY - GILD
46%
Loosely correlated
-1.46%
GSK - GILD
44%
Loosely correlated
-0.44%
ABBV - GILD
43%
Loosely correlated
-1.12%
PFE - GILD
42%
Loosely correlated
-0.45%
More